-
Something wrong with this record ?
Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-Sectional Study
R. Sharma, M. Chhabra, K. Vidyasagar, M. Rashid, D. Fialova, AS. Bhagavathula,
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2013
PubMed Central
from 2015
Europe PubMed Central
from 2015
ProQuest Central
from 2013-03-01
Open Access Digital Library
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- Publication type
- Journal Article MeSH
Background: Older patients with type 2 diabetes mellitus (T2DM) are at greater risk of receiving potentially inappropriate medications (PIM) during hospitalization which may result in adverse outcomes. Aim: To evaluate the extent of PIM use in the older population with T2DM during hospitalization in a tertiary care hospital in India. Methods: A cross-sectional study was carried out from August 2019 to January 2020 in a tertiary care teaching hospital among the older population (aged ≥ 65 years) hospitalized with T2DM. Medications prescribed during hospitalization were reviewed following Beers Criteria 2019 to identify the extent of polypharmacy and PIM use. Binary logistic regression was applied to determine the factors associated with PIM use. Results: The mean age of the 150 patients hospitalized with T2DM was 68.85 ± 5.51 years, most of whom were men (54.7%). The participants had at least four comorbidities and were receiving an average of nine medications per day; the median length of hospital stay was 8 days (interquartile range (IQR): 4-19 days). Overall, three quarters (74%) of the participants had at least one PIM prescribed during their hospitalization as per Beers Criteria. Significant factors associated with the use of PIM during hospitalization are patients taking a higher number of medications (odds ratio (OR): 7.85, 95% CI 1.49-41.10), lower creatinine clearance values (OR: 12.90, 95% CI 2.81-59.28) and female patients (OR: 2.29; 95% CI: 1.05-4.97). Conclusions: PIM use is frequently observed in older T2DM patients during hospitalization. Polypharmacy, reduced renal function and female gender are associated with higher PIM use. Engaging clinical pharmacists in evaluating medication appropriateness can improve the outcomes of older patients.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21001741
- 003
- CZ-PrNML
- 005
- 20221031130239.0
- 007
- ta
- 008
- 210105s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pharmacy8040219 $2 doi
- 035 __
- $a (PubMed)33212819
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sharma, Rishabh $u Department of Pharmacy Practice, Indo-Soviet Friendship College of Pharmacy, Moga 142001, Punjab, India.
- 245 10
- $a Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-Sectional Study. / $c R. Sharma, M. Chhabra, K. Vidyasagar, M. Rashid, D. Fialova, AS. Bhagavathula,
- 520 9_
- $a Background: Older patients with type 2 diabetes mellitus (T2DM) are at greater risk of receiving potentially inappropriate medications (PIM) during hospitalization which may result in adverse outcomes. Aim: To evaluate the extent of PIM use in the older population with T2DM during hospitalization in a tertiary care hospital in India. Methods: A cross-sectional study was carried out from August 2019 to January 2020 in a tertiary care teaching hospital among the older population (aged ≥ 65 years) hospitalized with T2DM. Medications prescribed during hospitalization were reviewed following Beers Criteria 2019 to identify the extent of polypharmacy and PIM use. Binary logistic regression was applied to determine the factors associated with PIM use. Results: The mean age of the 150 patients hospitalized with T2DM was 68.85 ± 5.51 years, most of whom were men (54.7%). The participants had at least four comorbidities and were receiving an average of nine medications per day; the median length of hospital stay was 8 days (interquartile range (IQR): 4-19 days). Overall, three quarters (74%) of the participants had at least one PIM prescribed during their hospitalization as per Beers Criteria. Significant factors associated with the use of PIM during hospitalization are patients taking a higher number of medications (odds ratio (OR): 7.85, 95% CI 1.49-41.10), lower creatinine clearance values (OR: 12.90, 95% CI 2.81-59.28) and female patients (OR: 2.29; 95% CI: 1.05-4.97). Conclusions: PIM use is frequently observed in older T2DM patients during hospitalization. Polypharmacy, reduced renal function and female gender are associated with higher PIM use. Engaging clinical pharmacists in evaluating medication appropriateness can improve the outcomes of older patients.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chhabra, Manik $u Department of Pharmacy Practice, Indo-Soviet Friendship College of Pharmacy, Moga 142001, Punjab, India.
- 700 1_
- $a Vidyasagar, Kota $u Department of Pharmaceutical Sciences, University College of Pharmaceutical Sciences, Hanamkonda 506009, Telangana, India.
- 700 1_
- $a Rashid, Muhammed $u Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B G Nagara 571448, Karnataka, India.
- 700 1_
- $a Fialova, Daniela $u Department of Social and Clinical Pharmacy, Faculty of Phamacy, 50005 Hradec Králové, Czech Republic. Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, 12000 Prague, Czech Republic.
- 700 1_
- $a Bhagavathula, Akshaya S $u Department of Social and Clinical Pharmacy, Faculty of Phamacy, 50005 Hradec Králové, Czech Republic. Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, 12000 Prague, Czech Republic.
- 773 0_
- $w MED00194323 $t Pharmacy $x 2226-4787 $g Roč. 8, č. 4 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33212819 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20221031130237 $b ABA008
- 999 __
- $a ind $b bmc $g 1613997 $s 1122025
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c 4 $e 20201117 $i 2226-4787 $m Pharmacy : $n Pharmacy (Basel) $x MED00194323
- LZP __
- $a Pubmed-20210105